Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ECRI Urges FDA To Host More Workshops On Device Bar-Coding Feasibility

This article was originally published in The Gray Sheet

Executive Summary

Additional workshops between FDA and stakeholders on device bar-coding feasibility are warranted while the agency investigates mandating bar-coding for devices, according to an 1ECRI white paper

You may also be interested in...



CDRH Expresses Renewed Interest In Unique Device Identifiers

CDRH Director Dan Schultz says the creation of a universal identifier system that could track the distribution of individual devices is feasible, in spite of industry concerns that such a system could be too costly

CDRH Expresses Renewed Interest In Unique Device Identifiers

CDRH Director Dan Schultz says the creation of a universal identifier system that could track the distribution of individual devices is feasible, in spite of industry concerns that such a system could be too costly

Bar Coding Advocacy Gathers Momentum? FDA, Rep. Sessions Scan Options

Rep. Pete Sessions (R-Texas) is urging FDA to explore a bar code requirement for medical devices

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022601

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel